$0.0110
-0.18-94.25%
Last update: Nov 9, 11:54 AM
NKGEN BIOTECH INC by NKGen Biotech Inc.
NKGNOTCEM
NKGEN BIOTECH INC by NKGen Biotech fell 45.0% from $0.02 to $0.01, behind the S&P 500's +10.0%. Its worst day was Jul 30 (−83.2%), and its low came Sep 4 at $0.00.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.04 was reported on $0.00 revenue.
0.0% · S&P 500 −2.0%
NKGEN BIOTECH INC by NKGen Biotech closed at its highest level of the year, 900.0% above where the year started.
Story events cover the past 12 months · Times ET
+233.3% · S&P 500 +0.2%
NKGEN BIOTECH INC by NKGen Biotech shares rose 185.7%, while the S&P 500 fell 0.6%.
+185.7% · S&P 500 −0.6%
NKGEN BIOTECH INC by NKGen Biotech shares rose 216.7%, while the S&P 500 rose 0.3%.
+216.7% · S&P 500 +0.3%
NKGEN BIOTECH INC by NKGen Biotech closed at its lowest level of the year, 90.0% below where the year started.
−4.8% · S&P 500 −0.4%
NKGEN BIOTECH INC by NKGen Biotech shares rose 471.4%, while the S&P 500 fell 0.0%.
+471.4%, the year's best day · S&P 500 0.0%
NKGEN BIOTECH INC by NKGen Biotech shares rose 428.6%, while the S&P 500 rose 0.7%.
+428.6% · S&P 500 +0.7%
NKGEN BIOTECH INC by NKGen Biotech shares rose 300.0%, while the S&P 500 fell 0.5%.
+300.0% · S&P 500 −0.5%
Where it ended: a close of $0.01 on Nov 9, 2026. Up next: Q3 2025 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All NKGN analyst actionsNothing in the past 12 months.
All NKGN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NKGN and SPY from Benzinga historical bars. Not investment advice.
